BWX Technologies reported a decrease in revenue to $528 million compared to $542 million in the first quarter of 2020. Earnings per share were $0.73. The company highlighted new wins in microreactor programs, agreements and progress in medical isotopes, and the completion of a multi-year pricing agreement with Naval Reactors, contributing to a robust backlog of nearly $5.2 billion.
Generated earnings of $0.73 per share on revenue of $528 million.
Maintained a strong backlog of nearly $5.2 billion, driven by Naval Reactors bookings and other wins.
Reiterated 2021 non-GAAP earnings guidance of $3.05 to $3.20 per share.
Commenced a new multi-year guidance framework for growth, free cash flow, and capital allocation.
BWXT reiterated all components of 2021 guidance:
Visualization of income flow from segment revenue to net income